Ampio Pharm
Ampio Pharmaceuticals, Inc., a biopharmaceutical company, engages in the development of therapies for the treatment of osteoarthritis of the knee (OAK) in the United States. The company develops OA-201, a small molecule formulation for the treatment of OAK pain. Ampio Pharmaceuticals, Inc. is based in Englewood, Colorado.
Ampio Pharm (AMPE) - Total Assets
Latest total assets as of December 2023: $5.74 Million USD
Based on the latest financial reports, Ampio Pharm (AMPE) holds total assets worth $5.74 Million USD as of December 2023.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Ampio Pharm - Total Assets Trend (2006–2023)
This chart illustrates how Ampio Pharm’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Ampio Pharm - Asset Composition Analysis
Current Asset Composition (December 2023)
Ampio Pharm's total assets of $5.74 Million consist of 100.0% current assets and 0.0% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 71.3% |
| Accounts Receivable | $920.00K | 16.0% |
| Inventory | $1.00 | 0.0% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2006–2023)
This chart illustrates how Ampio Pharm's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Ampio Pharm's current assets represent 100.0% of total assets in 2023, an increase from 0.0% in 2006.
- Cash Position: Cash and equivalents constituted 71.3% of total assets in 2023, up from 0.0% in 2006.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2006.
- Asset Diversification: The largest asset category is accounts receivable at 16.0% of total assets.
Ampio Pharm Competitors by Total Assets
Key competitors of Ampio Pharm based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Halozyme Therapeutics Inc
NASDAQ:HALO
|
USA | $2.22 Billion |
|
Biomarin Pharmaceutical Inc
NASDAQ:BMRN
|
USA | $7.59 Billion |
|
ESSA Pharma Inc
NASDAQ:EPIX
|
USA | $110.50 Million |
|
Shenzhen CAU Technology Co Ltd
SHE:000004
|
China | CN¥260.55 Million |
|
Pacific Shuanglin Bio pharmacy Co Ltd
SHE:000403
|
China | CN¥9.58 Billion |
|
Nanhua Bio Medicine Co Ltd
SHE:000504
|
China | CN¥841.96 Million |
|
Jiangsu Sihuan Bioengineering Co Ltd
SHE:000518
|
China | CN¥509.14 Million |
|
Chengzhi Shareholding Co Ltd
SHE:000990
|
China | CN¥27.52 Billion |
Ampio Pharm - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Ampio Pharm generates 0.00x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Ampio Pharm is currently not profitable relative to its asset base.
Ampio Pharm - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.41 | 11.18 | 3.69 |
| Quick Ratio | 2.41 | 11.18 | 3.69 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $3.36 Million | $ 12.14 Million | $ 4.19 Million |
Ampio Pharm - Advanced Valuation Insights
This section examines the relationship between Ampio Pharm's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.00 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | -57.8% |
| Total Assets | $5.74 Million |
| Market Capitalization | $670.80 USD |
Valuation Analysis
Below Book Valuation: The market values Ampio Pharm's assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Ampio Pharm's assets decreased by 57.8% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Ampio Pharm (2006–2023)
The table below shows the annual total assets of Ampio Pharm from 2006 to 2023.
| Year | Total Assets | Change |
|---|---|---|
| 2023-12-31 | $5.74 Million | -57.79% |
| 2022-12-31 | $13.59 Million | -65.00% |
| 2021-12-31 | $38.83 Million | +69.70% |
| 2020-12-31 | $22.88 Million | +63.40% |
| 2019-12-31 | $14.00 Million | -0.21% |
| 2018-12-31 | $14.03 Million | -8.39% |
| 2017-12-31 | $15.31 Million | +12.64% |
| 2016-12-31 | $13.60 Million | -73.03% |
| 2015-12-31 | $50.42 Million | -28.25% |
| 2014-12-31 | $70.27 Million | +95.09% |
| 2013-12-31 | $36.02 Million | +39.35% |
| 2012-12-31 | $25.85 Million | +32.67% |
| 2011-12-31 | $19.48 Million | +2541.62% |
| 2010-12-31 | $737.52K | +2303.85% |
| 2009-12-31 | $30.68K | -6.85% |
| 2008-12-31 | $32.94K | +3.74% |
| 2007-12-31 | $31.75K | +5.29% |
| 2006-12-31 | $30.15K | -- |